#United States #Nashville #CryoPort #MVE #Fusion 800

Cryoport Launches the MVE Fusion® 800 Series

Cryoport, Inc., a leader in temperature-controlled supply chain solutions for the life sciences, has unveiled its advanced MVE Fusion® 800 Series. This innovative series is a significant evolution in cryogenic storage technology, particularly tailored for environments with limited space. The MVE Fusion 800 freezer sets new standards by eliminating the reliance on a constant liquid nitrogen supply, a move that enhances reliability, safety, and sustainability.

Recognized with the esteemed ISBER Outstanding New Product Award, the MVE Fusion technology has already made waves in the biopharmaceutical sector, and the latest iteration continues this trend. With its sleek design measuring just 32 inches in width, it is not only compact enough to navigate through standard doorways but also designed for effortless installation — all without incurring expenses associated with significant facility modifications.

Mike Duich, President and CEO of MVE Biological Solutions, expressed his enthusiasm for this launch, stating, "The Fusion 800 is a major evolution and a step forward into the future. It provides our customers with unmatched storage density, flexibility, and operational capabilities while eliminating the infrastructure challenges posed by traditional cryogenic systems. This product paves the way for more facilities to adopt genuine cryogenic storage solutions safely."

The MVE Fusion 800 is ideal for various applications, including medical research facilities, hospital pharmacies, biorepositories, and blood and tissue banks. It offers versatile storage options, ensuring that critical biological materials are maintained at steady, ultra-low temperatures (at or below -150°C), thus safeguarding life-saving therapies.

"Transitional products that truly redefine the industry are rare; however, the MVE Fusion 800 stands out as one of them," commented Jerrell Shelton, CEO of Cryoport. "It addresses a long-standing challenge in cryogenic storage, ensuring the protection of vital biological materials without the spatial and infrastructural limitations that characterize legacy cryogenic systems. We are confident that the Fusion 800 will become the new benchmark in laboratories and pharmacies around the globe."

This cutting-edge cryogenic freezer not only enhances operational efficiency but also delivers economic advantages to organizations that need reliable storage without the burden of extensive infrastructure investments. As such, it represents a critical tool in the ongoing efforts to advance biopharmaceutical research and medical development.

About Cryoport, Inc.

Founded to meet the evolving needs of the life sciences, Cryoport, Inc. specializes in offering temperature-controlled supply chain solutions. The company collaborates with biopharmaceutical firms, contract manufacturers, and research organizations through a holistic suite of products and services aimed at minimizing risk and maximizing efficiency. Their integrated platform includes logistics management, biologistics, biostorage, and cryogenic services, which are vital for the temperature-sensitive materials associated with regenerative medicine.

To learn more about the MVE Fusion® 800 Series and Cryoport's innovative solutions, visit Cryoport's website or reach out to an MVE distributor for inquiries.

Stay updated with the latest advancements from Cryoport by following them on LinkedIn or X (formerly Twitter) for real-time updates.

(Disclaimer: The statements made in this article are subject to risks and uncertainties in the market that could affect actual performance. For a detailed analysis, please refer to Cryoport's SEC filings.)